| Estimated onset of any restriction | Estimated persistence of any restriction |
---|---|---|
 | % (95% CI) | % (95% CI) |
Overall | 29.8 (27.6, 32.0) | 68.8 (66.2, 71.3) |
Gender | Â | Â |
Females | 29.0 (26.1, 32.1) | 72.4 (69.1, 75.4) |
Males | 30.6 (27.6, 33.8) | 63.9 (59.8, 67.8) |
Age group | Â | Â |
Overall | Â | Â |
50–59 years | 26.4 (23.4, 29.6) | 62.8 (58.5, 66.9) |
60–69 years | 26.7 (23.4, 30.4) | 63.6 (58.9, 68.1) |
70–79 years | 36.9 (31.8, 42.3) | 74.7 (69.5, 79.2) |
80+ yrs | 48.0 (35.5, 60.8) | 86.3 (77.7, 91.2) |
Females | Â | Â |
50–59 years | 25.4 (21.4, 29.6) | 66.3 (60.6, 71.5) |
60–69 years | 26.5 (22.0, 31.6) | 69.3 (63.2, 74.9) |
70–79 years | 35.1 (28.1, 42.8) | 75.0 (68.4, 80.6) |
80+ yrs | 51.4 (33.2, 69.2) | 89.6 (80.7, 94.7) |
Males | Â | Â |
50–59 years | 27.4 (23.0, 32.3) | 58.4 (51.7, 64.7) |
60–69 years | 27.0 (22.3, 32.2) | 56.8 (49.6, 63.7) |
70–79 years | 38.8 (31.7, 46.4) | 74.2 (65.5, 81.4) |
80+ yrs | 45.1 (28.4, 63.0) | 79.7 (59.6, 91.3) |